Please login to the form below

Not currently logged in
Email:
Password:

Zika virus

This page shows the latest Zika virus news and features for those working in and with pharma, biotech and healthcare.

Moderna files record $500m IPO for RNA pipeline

Moderna files record $500m IPO for RNA pipeline

as well as vaccines for viral infections such as respiratory syncytial virus (RSV), influenza, chikungunya and Zika.

Latest news

  • Takeda gets FDA fast-track status for Zika vaccine Takeda gets FDA fast-track status for Zika vaccine

    Takeda’s efforts to develop an effective vaccine against Zika virus have earned it a fast-track designation from the US FDA. ... Takeda is thought to be furthest ahead in development with TAK-426 - a purified, inactivated, alum-adjuvanted, whole Zika

  • Sanofi and Merck & Co finalise vaccine alliance split Sanofi and Merck & Co finalise vaccine alliance split

    The French company also began research for a potential Zika vaccine in February last year. ... World Health Organization vaccines specialist Marie Paule Kieny said that the trial results were a “game-changer” for patients and for fighting future

  • Making a list and checking it twice… Making a list and checking it twice…

    Just a few weeks ago, the WHO declared that the Zika Public Health Emergency was over. ... The last few years have seen the (re) emergence of dengue, ebola, measles, West Nile virus, avian influenza and MERS.

  • EMA creates Zika virus task force EMA creates Zika virus task force

    There are currently no vaccines or medicines to protect from or treat Zika virus infection that are approved or undergoing clinical studies. ... Meanwhile, GlaxoSmithKline is reportedly considering assessing the suitability of its current vaccine

  • Sanofi embarks on Zika vaccine hunt Sanofi embarks on Zika vaccine hunt

    Sanofi's vaccine division has started an R&D programme to try to find a vaccine against the Zika virus, which has been called a 'global emergency' by the World Health ... Like dengue, Zika virus (ZIKV) is a member of the Flavivirus genus - which includes

More from news
Approximately 5 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    up. Turning to the battle against the Zika virus, BARDA announced three more grants for vaccine development to Takeda (up to $312m), Moderna [up to $125m] and Sanofi ($43.2m). ... In a similar vein Sanofi will receive $43.2m in funding for the mid stage

  • Deal Watch June 2016 Deal Watch June 2016

    Indeed studies in Brazil and French Polynesia have already reported transfusion-transmitted Zika virus. ... collaboration, licence. 200. Cerus/ BARDA. Intercept, pathogen reduction technology for blood transfusions including Zika virus.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Cool heads in a crisis?

    First there was Ebola and now there is Zika; two official World Health Organization (WHO) Public Health Emergencies of International Concern (PHEIC) within as many years.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics